Are most menopausal women getting hormone therapy that could help them?
No. A large U.S. study found that menopausal hormone therapy use fell from 4.4% of women in 2007 to just 1.7% in 2023. Even among women aged 50 to 59, the group most likely to benefit, only about 3.5% were using it in 2023.
Menopause happens when a woman’s ovaries slow down and her body makes far less estrogen. This change can bring hot flashes, night sweats, poor sleep, and other symptoms that disrupt daily life. Hormone therapy replaces some of that lost estrogen, and for many women it is one of the most effective ways to ease these symptoms. Yet this study shows that very few women are actually using it.
What the data show
Researchers looked at a large nationwide U.S. health database covering women aged 40 and older. Over a 16-year span, hormone therapy use dropped by more than half, falling from 4.4% in 2007 to 1.7% in 2023. That decline held even when researchers narrowed the focus to women aged 50 to 59, where use sat at only about 3.5% by 2023. This is the exact group that tends to gain the most from treatment, which makes the low number striking.
The study also found that use was consistently lower among Black, Hispanic, and Asian American women. So not only is overall treatment rare, it is also unevenly spread across different groups of women. Meanwhile, up to 75% of menopausal women report symptoms, which leaves a large share of them undertreated.
Dr. Kumar’s Take
What strikes me about this study is the gap between what the science says and what is actually happening in clinics. We have strong evidence that hormone therapy is safe and effective for many women, especially those in their fifties who are close to the start of menopause. And yet the numbers keep falling. A lot of this traces back to fear that lingered after older research raised alarms about risks, fears that later, more careful analysis has largely walked back for younger menopausal women. I think many women never get offered the option at all, and many doctors stay cautious out of old habits. The result is millions of women quietly suffering through symptoms that we know how to treat.
Who this affects most
The women most likely to miss out are those in their fifties with bothersome symptoms, the very people who stand to benefit. The drop in use among Black, Hispanic, and Asian American women is a real concern, because it points to unequal access and unequal conversations in the doctor’s office. When a treatment that works is used this rarely, and used even less in some communities, the burden of untreated menopause does not fall evenly.
Why the numbers stayed low
Part of the story is history. Two decades ago, a major trial raised worries about hormone therapy and breast cancer, and use dropped sharply afterward. Later reviews showed that the original scare was overstated for many women, particularly those who start treatment near the beginning of menopause. But the caution stuck. This study suggests that the correction in the science never fully reached everyday practice, so the safety message many women heard is still out of date.
Practical Takeaways
- If menopause symptoms like hot flashes, night sweats, or poor sleep are affecting your life, ask your doctor directly whether hormone therapy is a safe option for you.
- Bring up your age and how recently your symptoms started, since women closer to the start of menopause often have the best balance of benefit and safety.
- If you have heard that hormone therapy is dangerous, ask your doctor to walk you through the current evidence, which has shifted a lot since the early 2000s.
- Do not assume the topic will come up on its own, as this study shows many women are never offered treatment they might benefit from.
Related Studies and Research
- Why the Women’s Health Initiative breast cancer scare was just a scratch
- Long-term oxygen treatment trial (LOTT) and health benefits
- Which exercises lower blood pressure the most over a full day?
- Effects of cold stimulation on cardiac-vagal activation and HRV
FAQs
Is hormone therapy safe for menopause?
For many women, especially those in their fifties who start treatment near the beginning of menopause, the current evidence supports hormone therapy as a safe and effective choice. The fears that drove use down years ago came from studies that often involved older women starting treatment long after menopause began. Risk is not the same for everyone, so safety depends on your age, your health history, and how recently your symptoms started. The best step is a personal conversation with your doctor about your own situation.
Why has hormone therapy use dropped so much?
A large trial in the early 2000s raised concerns about risks like breast cancer, and use fell sharply soon after. Later analysis showed those risks were overstated for younger menopausal women, but the original message stuck in the minds of both patients and doctors. This study suggests that the updated, more reassuring evidence never fully reshaped everyday practice. As a result, use kept falling even as the science grew more supportive.
How many menopausal women have symptoms?
Up to 75% of menopausal women report symptoms such as hot flashes, night sweats, and sleep problems. Despite this, only a small fraction use hormone therapy, with this study finding just 1.7% of women aged 40 and older using it in 2023. That mismatch is the heart of the problem the researchers describe. It means a large share of women are living with treatable symptoms without effective help.
Bottom Line
This study shows a clear and troubling gap. Menopausal hormone therapy use in U.S. women fell from 4.4% in 2007 to just 1.7% in 2023, and even the women most likely to benefit are rarely using it. Strong evidence that this treatment is safe and effective for many women has not made its way into clinical practice, and use is especially low among Black, Hispanic, and Asian American women. With up to 75% of menopausal women reporting symptoms, the takeaway is simple: too many women are undertreated, and the conversation about hormone therapy deserves to happen far more often than it does.
